RVL Pharmaceuticals PLC RVLP

Market cap
$14.1M
P/E
0.0×
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
1.39 1.39 1.33 1.53 3.41 4.99 2.08
P/FCF ratio
13.31 13.31 10.50 12.36 17.86 0.00 0.00
P/Operating CF
48.33 48.33 11.55 542.29 (31.29) (3.58) (6.28)
P/B ratio
0.84 0.84 0.91 3.19 2.75 1.14 2.02
EV/Sales
2.52 2.52 2.08 2.25 4.82 5.32 2.33
EV/EBITDA
10.88 10.88 6.29 9.00 13.23 0.00 0.00
EV/FCF
24.13 24.13 16.42 18.24 25.26 (1.65) (3.00)
Current Ratio
0.80 0.92 1.51 2.27 3.10 2.95 2.89
Net Debt/EBITDA
23.78 4.24 2.27 2.90 27.89 (0.09) (0.29)
Debt/Equity
0.71 0.74 0.70 2.36 2.35 0.60 1.11
ROE
(9.28%) (9.13%) (26.76%) (108.67%) (76.32%) (76.11%) (80.88%)
ROA
(4.41%) (4.33%) (12.79%) (43.04%) (19.08%) (25.18%) (37.84%)
ROIC
(2.59%) (4.51%) (10.59%) (60.70%) (28.25%) (62.69%) (58.06%)
Return on Tangible Assets
(1,018.09%) (190.82%) (122.38%) (213.42%) (66.46%) (161.75%) (134.17%)
Average Days of Receivables
75.72 55.90 78.10 66.78 41.40 44.49 22.25
Earnings Yield
(61.23%) (61.23%) (64.39%) (73.68%) (31.31%) (87.96%) (48.70%)
Free Cash Flow Yield
7.51% 7.51% 9.53% 8.09% 5.60% (64.70%) (37.34%)
Free Cash Flow per Share
(60.72) 1.19 0.74 0.57 0.24 (0.84) (0.43)
Book value per Share
465.21 10.17 8.48 2.19 1.55 1.14 0.57
Free Cash Flow
(60.72) 50.94 33.42 29.62 14.46 (56.51) (38.56)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates